SBCMA predicts progression and is a biomarker of response in myeloma precursor disease followed on prospective studies

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)

引用 0|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要